FDA Proposes Framework to Advance Credibility of AI Models Used for Drug and Biological Product Submissions

SILVER SPRING, Md., Jan. 6, 2025 /PRNewswire/ — Today, the U.S. Food and Drug Administration issued draft guidance to provide recommendations on the use of artificial intelligence (AI) intended to support a regulatory decision about a drug or biological product’s safety, effectiveness or…